Skip to content

Drug interactions

Desvenlafaxine + Lomitapide

Severity: Minor

Desvenlafaxine and Lomitapide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Desvenlafaxine is only a weak CYP3A4 inhibitor, and it is mainly cleared by conjugation, so any rise in lomitapide exposure is expected to be small. Lomitapide is a sensitive CYP3A4 substrate, and higher levels increase the risk of hepatotoxicity and gastrointestinal adverse effects. The clinical significance is probably limited.

What this interaction means in plain words

Desvenlafaxine and Lomitapide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Desvenlafaxine belongs to Central Nervous System; Lomitapide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4-mediated lomitapide metabolism by desvenlafaxine.

What to do

Keep lomitapide at the dose set by its labeling and monitor ALT, AST and bilirubin as routinely required. Reassess if gastrointestinal intolerance or liver enzyme elevation appears.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Desvenlafaxine and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Desvenlafaxine with Lomitapide?

MediHelp rates the interaction as minor. Desvenlafaxine and Lomitapide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Desvenlafaxine is only a weak CYP3A4 inhibitor, and it is mainly cleared by conjugation, so any rise in lomitapide exposure is expected to be small. Lomitapide is a sensitive CYP3A4 substrate, and higher levels increase the risk of hepatotoxicity and gastrointestinal adverse effects. The clinical significance is probably limited.

How serious is the interaction between Desvenlafaxine and Lomitapide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Keep lomitapide at the dose set by its labeling and monitor ALT, AST and bilirubin as routinely required. Reassess if gastrointestinal intolerance or liver enzyme elevation appears.

What other medicines interact with Desvenlafaxine?

MediHelp also lists interactions of Desvenlafaxine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Desvenlafaxine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in